Last updated on December 2019
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus
Brief description of study
The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).
Clinical Study Identifier: NCT03616964
